GSK trails after Pfizer in 5-in-1 meningococcal vaccine race

[cafead]

via The FDA has started a review of GSK’s five-in-one meningococcal vaccine, cueing up a decision in mid-February next year, as it tries to chase down a rival candidate from Pfizer cleared last year.

article source